Harriette R Mogul
Affiliation: New York Medical College
- Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trialHarriette R Mogul
Department of Medicine, Division of Endocrinology, New York Medical College, 490 Munger Pavilion, Valhalla, New York 10595, USA
J Clin Endocrinol Metab 93:1238-45. 2008..Its use in PWS adults has been limited by documentation of benefits and risks, as determined by larger multisite studies...
- Metformin and carbohydrate-modified diet: a novel obesity treatment protocol: preliminary findings from a case series of nondiabetic women with midlife weight gain and hyperinsulinemiaH R Mogul
Division of Endocrinology, New York Medical College, Valhalla, New York, USA
Heart Dis 3:285-92. 2001..The authors concluded that metformin and carbohydrate-modified hypocaloric diet could be an effective novel treatment for long-term weight management in nondiabetic, hyperinsulinemic women...
- Syndrome W: a new model of hyperinsulinemia, hypertension and midlife weight gain in healthy women with normal glucose toleranceHarriette R Mogul
Division of Endocrinology, Department of Medicine, New York Medical College, Valhalla, New York 10595, USA
Heart Dis 4:78-85. 2002..The identification of Syndrome W before the onset of overt impaired glucose tolerance, diabetes, or manifestations of coronary artery disease could have important clinical and public health implications for midlife women...
- Long-term (2-4 year) weight reduction with metformin plus carbohydrate-modified diet in euglycemic, hyperinsulinemic, midlife women (Syndrome W)Harriette R Mogul
Divisions of Endocrinology, Department of Medicine, New York Medical College, Valhalla, NY 10595, USA
Heart Dis 5:384-92. 2003....
- Obesity: new perspectives and pharmacotherapiesKerri L Palamara
Department of Medicine, Harvard Medical School Massachusetts Medical General Hospital, Boston, Massachusetts, USA
Cardiol Rev 14:238-58. 2006..Pharmacologic agents are in clinical development that target these substances...